Skip to main content
. 2022 Feb;84(1):111–119. doi: 10.18999/nagjms.84.1.111

Table 1.

Patients’ background characteristics (n = 61)

Linked seed brachytherapy
28 cases
Loose seed brachytherapy
33 cases
Age (years) 58–74 median 69 years 56–78 median 70 years
FirstPSA (ng/ml) 4.1–22.61 median 6.5 4.6–56.3 median 7.2
Seed numbers Monotherapy
(160Gy)
52–95 median 80 65–100 median 80
External beam
radiotherapy
(110Gy)
42–90 median 60 45–60 median 50
Clinical staging cT1c 13 6
cT2a 6 14
cT2b 8 6
cT2c 1 3
cT3a 0 4
Gleason score 3 + 3 17 15
3 + 4 7 8
4 + 3 3 7
over 4 + 4 1 3
Risk Low 13 13
Intermediate 14 12
High 1 8
External beam
radiotherapy
Yes 11 14
No 17 19